Saturday, September 26, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Regulatorygray-marketchinachad-wolfimport-controls

Former DHS chief Chad Wolf says China supplies mislabeled US peptides

Wolf told NewsNation that ingredients enter through customs under one label, are repackaged and resold, and compares the pattern to early fentanyl precursor flows.

DO
By Daniel Okafor · Regulatory Correspondent
Sep 26 03:20 ETSource: AOL.com

The wire

  1. 01Former acting DHS Secretary Chad Wolf said on Elizabeth Vargas Reports that many US peptide users believe they are injecting FDA-approved drugs but are receiving unapproved experimental material routed through China and middlemen.
  2. 02The claim adds a homeland-security frame to gray-market peptide supply, a pressure point for clinics, telehealth sellers and compounders already facing FDA scrutiny.
  3. 03Wolf offered no data on volumes or seizures and acknowledged peptides from reputable sources are not necessarily dangerous; the remarks are an interview claim, not an enforcement action.

From the source

China profiting off US peptide interest, Chad Wolf says

( NewsNation ) — Peptides have become increasingly popular among influencers and celebrities who use them in hopes of reversing aging, recovering from sports injuries, regulating blood sugar and reducing inflammation.

Read at aol.com
PeptiPrescribed peptides from $99/moSee all →